GSK Gets Japan Approval for Prefilled Shingrix Syringe

03:30 AM EDT, 09/10/2026 (MT Newswires) -- GSK (GSK) said Thursday that Japan's Ministry of Health, Labour and Welfare approved a prefilled syringe version of Shingrix for shingles prevention. The drugmaker said the vaccine was previously supplied in two vials that had to be mixed before use. The company said the prefilled syringe is ready to use, simplifying administration for healthcare professionals. GSK launched the prefilled syringe in the US in February 2026 and is rolling it out in Europe throughout this year.